Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Weight loss drug Mounjaro debuts, rivals in hot pursuit
Mint Mumbai
|March 21, 2025
US company is pricing the anti-obesity treatment from ₹14,000 to ₹17,500 a month in India
S drugmaker Eli Lilly & Co. brought its anti-obesity drug Mounjaro to India on Thursday, marking the country's first treatment of its kind, with monthly costs ranging from ₹14,000 to ₹17,500. The new drug, however, will face competition soon enough, with other foreign pharmaceutical companies planning to introduce similar products in a growing market.
Mounjaro's 2.5mg and 5mg vials will be priced at ₹3,500 and ₹4,375 respectively, in India. The injectable drug, used to treat obesity and type-2 diabetes, is to be taken once a week. The company had previously stated that it would price the drug, which costs around $1,000 per month ($86,315) in the US, competitively in India. "This India-specific pricing reflects Lilly's commitment to expanding access to innovative treatments in the country," the company said on Thursday.
Diese Geschichte stammt aus der March 21, 2025-Ausgabe von Mint Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Mumbai
Mint Mumbai
Paint firms strengthen moats as competition heats up
A bruising market-share battle is escalating in India's ₹70,000-crore paints sector, forcing companies to look beyond aggressive discounting and instead strengthen their foothold in key geographical areas while sharpening their product portfolios.
2 mins
November 28, 2025
Mint Mumbai
Telcos slam Trai penalty plan for financial report flaws
Trai has proposed turnover-linked penalties for filing incorrect, incomplete financial reports
2 mins
November 28, 2025
Mint Mumbai
Consumers warm up to Bolt as it aces 10-min hunger games
A year after launch, Bolt is emerging as Swiggy's fastest-scaling bet.
2 mins
November 28, 2025
Mint Mumbai
Doing India’s needy a good turn: Everyone is welcome to pitch in
What may seem weakly linked with positive outcomes on the ground could work wonders over time
3 mins
November 28, 2025
Mint Mumbai
GOING SOLO: FACING THE GROWING REALITY OF SOLITARY RETIREMENT IN INDIA
What we plan for ourselves isn't always what life plans for us.
2 mins
November 28, 2025
Mint Mumbai
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Mumbai
How the latest labour codes will benefit most employees
Workers may see an increase in some statutory benefits such as gratuity and leave encashment
4 mins
November 28, 2025
Mint Mumbai
Tune into weak signals in a world of data dominance
World War II saw the full fury of air power in battle, first exercised by Axis forces and then by the Allies, culminating in American B-29 bombers dropping atomic bombs on Hiroshima and Nagasaki.
4 mins
November 28, 2025
Mint Mumbai
Investors expect AI use to soar. That's not happening
An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.
2 mins
November 28, 2025
Mint Mumbai
Tech startups on M&A route to boost scale, market share
M&As were earlier used to enter new markets or geographies, but that strategy has evolved
2 mins
November 28, 2025
Listen
Translate
Change font size